SLN360
silence therapeutics
['sln360', 'dose,study', 'silence thera']
silence therapeutics presents new analysis from sln360 phase 1 single dose study in high lipoprotein(a) at the american heart association (aha) 2022 annual meeting 
News forum for top stories in Cardiac and Vascular to include cardiovascular, structural heart, PV, EVAR, TAVR, Interventional, neurovascular @PrimeCoreSearch